{"nct_id":"NCT02640833","title":"A Study of Duvelisib and Venetoclax in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Indolent or Aggressive Non-Hodgkin Lymphoma, Who Have Not Previously Received a Bcl-2 or PI3K Inhibitor","status":"WITHDRAWN","status_verified_date":"2016-07","start_date":"2016-07","start_date_type":null,"primary_completion_date":"2020-01","primary_completion_date_type":"ESTIMATED","completion_date":"2021-02","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["ABBV"]}